Hints and tips:
...The contracts will give the UK access to 1.75m additional courses of Merck Sharp and Dohme’s antiviral Lagevrio and an extra 2.5m courses of Pfizer’s Paxlovid pill....
...A spokesperson for Merck Sharp & Dohme – the name under which the US group operates in Europe – said it is cooperating fully with the CMA’s investigation, and said: MSD is confident that the proceedings...
...Mergers led the US company to become known as Merck Sharp & Dohme, which prompted a 1950s agreement for it to keep exclusive rights to the Merck name in North America while calling itself MSD everywhere...
...Mergers led the US company to become known as Merck Sharp & Dohme, and this spurred a 1950s agreement for it to keep exclusive rights to the family name in North America while calling itself MSD everywhere...
...To closures by Merck Sharp & Dohme, GlaxoSmithKline, Roche and Pfizer has now been added AstraZeneca’s re-organisation and reduction....
...Merck Sharp and Dohme, better known as MSD, has filed a case with Delhi’s High Court claiming that Glenmark, the Mumbai-listed pharmaceutical company, is violating patents on its diabetes drugs, Januvia...
...Merck Sharp and Dohme sells its patented diabetes drug Januvia in India for about $24 per month, 80 per cent lower than its global price....
...Sanofi-Aventis rose 3.4 per cent to €46.42 and Merck gained 2.6 per cent to €68.60....
...Defensive stocks, such as food and pharmaceuticals, sustained sharp losses in the morning, but some recovered, benefiting from investor rotation....
...Last year, it bought Merck Sharp & Dohme’s Ponders End API manufacturing site in north London. It has not divulged details of either that deal or the Queenborough purchase....
...But there was a strong performance from pharmaceuticals following a positive first quarter trading statement from US drugs giant Merck....
...Merck, meanwhile, jumped 6.8 per cent to €67.73 after the German drugs and chemicals group raised its profitability targets....
...AGF, which also reported a sharp rise in 2004 perofits and proposed a 44 per cent dividend increase, saw its shares gain 0.6 per cent to €58.65....
International Edition